Page last updated: 2024-11-01

ofloxacin and Vomiting

ofloxacin has been researched along with Vomiting in 5 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research Excerpts

ExcerptRelevanceReference
" Nausea, vomiting, and diarrhoea were the most frequently reported adverse events."2.74Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia. ( Calistru, PI; Castaing, N; Chernyak, V; Cooper, CA; Dartois, N; Gandjini, H; Milutinovic, S; Strausz, J; Tanaseanu, C; Zolubas, M, 2009)
"Clarithromycin resistance was indirectly assessed by the (13)C-urea breath test, with a post-treatment value cut-off point at 15."2.73Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy. ( Chang, WL; Chen, WY; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB, 2007)
" The study indicates that ofloxacin is a safe and effective agent in the treatment of various infections."1.27Clinical safety and efficacy of ofloxacin. ( Concia, E; Grossi, P; Malfitano, A; Marone, P; Perversi, L, 1988)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaseanu, C1
Milutinovic, S1
Calistru, PI1
Strausz, J1
Zolubas, M1
Chernyak, V1
Dartois, N1
Castaing, N1
Gandjini, H1
Cooper, CA1
Cheng, HC1
Chang, WL1
Chen, WY1
Yang, HB1
Wu, JJ1
Sheu, BS1
Flannery, MT1
Le, M1
Altus, P1
Stahlmann, R1
Marone, P1
Concia, E1
Grossi, P1
Malfitano, A1
Perversi, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Intravenous Tigecycline Vs Intravenous Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia[NCT00081575]Phase 3434 participants (Actual)Interventional2004-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for ofloxacin and Vomiting

ArticleYear
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.
    BMC pulmonary medicine, 2009, Sep-09, Volume: 9

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Diarrhea; Dose-Respon

2009
Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
    Helicobacter, 2007, Volume: 12, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin;

2007

Other Studies

3 other studies available for ofloxacin and Vomiting

ArticleYear
Endocarditis due to Salmonella.
    Southern medical journal, 2001, Volume: 94, Issue:4

    Topics: Aged; Anti-Infective Agents; Cardiac Catheterization; Ceftriaxone; Cephalosporins; Combined Modality

2001
Clinical toxicological aspects of fluoroquinolones.
    Toxicology letters, 2002, Feb-28, Volume: 127, Issue:1-3

    Topics: Anti-Infective Agents; Bacterial Infections; Cardiovascular Diseases; Central Nervous System Disease

2002
Clinical safety and efficacy of ofloxacin.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Drug Evaluation; Female; Humans; Male; Middle

1988